All-trans retinoic acid improves erythropoiesis in myelodysplastic syndromes: a case report

Related Experiment Videos

G Visani¹, A Cenacchi, P Tosi

¹Institute of Haematology, L. & A. Seràgnoli, University Hospital S. Orsola, Bologna, Italy.

British Journal of Haematology

|July 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Alcohol use and abuse: a cross-sectional study among Italian adolescents.

Journal of preventive medicine and hygiene·2018

MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine.

The pharmacogenomics journal·2017

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia.

Leukemia·2017

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Retraction: The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss.

EXCLI journal·2016

Radiological assessment of the PRF/BMSC efficacy in the treatment of aseptic nonunions: A retrospective study on 90 subjects.

Injury·2016

See all related articles